恩曲他滨

Zhongfu Pharmaceutical Co., Ltd mainly manufactures small volume water injections, powder for injections, tablets & capsules and APIs. The capacity is: 100 million of small volume water injections, 180 million of powder injections, one billion of tablets and capsules and 140 tons of APIs. The QC department is equipped with modern analytical instruments which can fully satisfy the analysis requirements to APIs, raw materials, chemical intermediates and R&D use. We set up perfect quality assurance system and quality control in every procedure which assure the quality of products. All of the facilities are GMP approved, operating with cGMP. Especially, among them, the Captopril API workshop was approved by US FDA in 1998 and passed the re-inspection of US FDA in 2004 with ZERO 483, we got COS certificate in 2007. We have set up business relationships with foreign partners for APIs including Captopril, Lisinopril, Hydralazine Hydrochloride etc. as well as finished dosage forms.